Our findings provide evidence that decreased drug efflux by knockdown ATP7A in CRC cells could lead up to higher tissue distribution and intracellular drug accumulation to form destructive DNA-platinum adducts which ultimately destroy cancer cells. The gene discussed is ATP7A; the disease is cancer.